Comparison of 3 Enzyme-Linked Immunoassay Methods to Evaluate Serum Concentrations of Infliximab and Antibodies to Infliximab in 32 Patients with Moderate to Severe Inflammatory Bowel Disease

BACKGROUND: Monitoring of trough levels and anti-drug antibodies is important when patients with inflammatory bowel disease (IBD) are treated with anti-TNF biologics due to guided therapeutic decisions. The comparability of 3 ELISA tests for detection of the lowest serum concentration of infliximab...

Descripción completa

Detalles Bibliográficos
Autores principales: Jukic, Tomislav, Drobne, David, Pusavec, Sasa, Ihan, Alojz, Stubljar, David, Starc, Andrej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2023
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945009/
https://www.ncbi.nlm.nih.gov/pubmed/36807319
http://dx.doi.org/10.12659/MSM.939084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945009/
https://www.ncbi.nlm.nih.gov/pubmed/36807319
http://dx.doi.org/10.12659/MSM.939084

Ejemplares similares